Clinical Gastroenterology Vol.18 No.9(4-7)

Theme Nonalcoholic Steatohepatitis (NASH)
Title Involvement of TGF-beta1 in NASH
Publish Date 2003/08
Author Masashi Yoneda Department of Gastroenterology, Dokkyo University School of Medicine
Author Takenao Hasegawa Second Department of Medicine, Asahikawa Medical College
Author Kimihide Nakamura Second Department of Medicine, Asahikawa Medical College
Author Akira Terano Department of Gastroenterology, Dokkyo University School of Medicine
[ Summary ] The pathogenesis of and therapy for non-alcoholic steatohepatitis (NASH) have not been establised. A two-hit theory is generally accepted but a factor for the second hit has not been determined. We hypothized that transforming growth factor-beta1 (TGF-beta1) is the factor for the second hit, and plasma TGF-beta1 levels in patients with NASH and those of patients with fatty livers were compared. Consequently, plasma TGF-beta1 levels in patients with NASH were significantly elevated, compared with those in fatty liver patients or healthy subjects. The elevated plasma TGF-beta1 levels were lowered through vitamine E treatment and there was improvement in hepatic function. These results suggest a possible role for TGF-beta1 in NASH and the usefulness of measurements of plasma TGF-beta1 to differentiate NASH from fatty liver cases.
back